Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV

20 Jan 2025

Abstract excerpt

Using the knowledge from decades of research into RNA-based therapies, the COVID-19 pandemic response saw the rapid design, testing and production of the first ever mRNA vaccines approved for human use in the clinic. This breakthrough has been a significant milestone for RNA therapeutics and vaccines, driving an exponential growth of research into the field. The development of novel RNA therapeutics targeting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA Interference and Gene Delivery
Share to Advanced biosensing and bioanalysis techniques
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39833468
DOI: 10.1007/s13346-025-01788-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIVPMID 39833468Read ↗

Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based deliverySemantic proximity Read ↗

Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSVSemantic proximity Read ↗

Prospects for RNAi Therapy of COVID-19Semantic proximity Read ↗

Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: A reviewSemantic proximity Read ↗

Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2Semantic proximity Read ↗

RNA interference as a promising treatment against SARS-CoV-2Semantic proximity Read ↗

siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses.Semantic proximity Read ↗

Design and Delivery of Therapeutic siRNAs: Application to MERS-CoronavirusSemantic proximity Read ↗

An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.Semantic proximity Read ↗

RNA interference and antiviral therapySemantic proximity Read ↗

In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2Semantic proximity Read ↗

In Silico and In Vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.